Definitive Healthcare (NASDAQ:DH) Upgraded by Wall Street Zen to Buy Rating

Definitive Healthcare (NASDAQ:DH) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday.

Several other brokerages also recently weighed in on DH. Canaccord Genuity Group reduced their price objective on shares of Definitive Healthcare from $4.00 to $3.00 and set a “hold” rating for the company in a research report on Friday, February 27th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Definitive Healthcare in a research report on Wednesday, January 21st. Zacks Research lowered shares of Definitive Healthcare from a “hold” rating to a “strong sell” rating in a research note on Thursday, March 5th. Morgan Stanley reissued an “underperform” rating and issued a $3.50 price target on shares of Definitive Healthcare in a research report on Thursday, December 18th. Finally, Stephens decreased their price objective on shares of Definitive Healthcare from $3.00 to $2.00 and set an “equal weight” rating for the company in a research note on Friday, February 27th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have issued a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, Definitive Healthcare currently has an average rating of “Reduce” and an average price target of $3.52.

Definitive Healthcare Stock Performance

NASDAQ:DH opened at $1.13 on Friday. Definitive Healthcare has a 12 month low of $1.07 and a 12 month high of $4.70. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.64 and a quick ratio of 1.64. The firm has a market capitalization of $159.74 million, a PE ratio of -0.90 and a beta of 1.66. The business’s fifty day moving average price is $1.89 and its 200 day moving average price is $2.69.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of DH. Invesco Ltd. raised its holdings in shares of Definitive Healthcare by 5.8% in the fourth quarter. Invesco Ltd. now owns 117,427 shares of the company’s stock valued at $337,000 after buying an additional 6,400 shares during the last quarter. XTX Topco Ltd increased its holdings in shares of Definitive Healthcare by 57.5% in the fourth quarter. XTX Topco Ltd now owns 75,306 shares of the company’s stock valued at $216,000 after purchasing an additional 27,495 shares during the period. Occudo Quantitative Strategies LP purchased a new stake in shares of Definitive Healthcare during the fourth quarter worth approximately $95,000. Millennium Management LLC raised its stake in shares of Definitive Healthcare by 230.9% during the fourth quarter. Millennium Management LLC now owns 332,087 shares of the company’s stock worth $953,000 after purchasing an additional 231,743 shares during the last quarter. Finally, Inspire Investing LLC lifted its holdings in shares of Definitive Healthcare by 505.7% during the fourth quarter. Inspire Investing LLC now owns 698,967 shares of the company’s stock worth $2,006,000 after purchasing an additional 583,562 shares during the period. 98.67% of the stock is owned by hedge funds and other institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.